MetaADEDB 2.0 @ LMMD
aclidinium bromide
(XLAKJQPTOJHYDR-QTQXQZBYSA-M)
Structure
SMILES
O=C(C(c1cccs1)(c1cccs1)O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2.[Br-]
Molecular Formula:
C26H30BrNO4S2
Molecular Weight:
564.555
Log P:
1.6296
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
112.24
CAS Number(s):
320345-99-1
Synonym(s)
1.
aclidinium bromide
2.
(3R)-3-((hydroxy(di-2-thienyl)acetyl)oxy)-1-(3-phenoxypropyl)-1-azoniabicyclo(2.2.2)octane bromide
External Link(s)
MeSHC542859
PubChem Compound11519741
ChEBI65344
CHEMBLCHEMBL551466
KEGGdr:D08837
Therapeutic Target DatabaseD07KHH
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Device malfunctionFAERS: 548
Canada Vigilance: 1
Canada Vigilance
US FAERS
2Drug dose omissionFAERS: 498US FAERS
3Product quality issueFAERS: 435
Canada Vigilance: 4
Canada Vigilance
US FAERS
4Intentional product misuseFAERS: 312US FAERS
5Intentional device misuseFAERS: 143US FAERS
6Device FailureFAERS: 119US FAERS
7MalaiseFAERS: 82US FAERS
8Product use issueFAERS: 78US FAERS
9Circumstance or information capable of leading to medication errorFAERS: 74US FAERS
10Memory impairmentFAERS: 71US FAERS
11PneumoniaFAERS: 65US FAERS
12Product use in unapproved indicationFAERS: 65US FAERS
13Visual ImpairmentFAERS: 59US FAERS
14Product dose omissionFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
15FatigueFAERS: 55US FAERS
16Feeling abnormalFAERS: 46US FAERS
17Drug ineffectiveFAERS: 45
Canada Vigilance: 5
Canada Vigilance
US FAERS
18DysgeusiaFAERS: 43US FAERS
19DysphoniaFAERS: 43US FAERS
20DizzinessFAERS: 41US FAERS
21Wrong technique in product usage processFAERS: 39US FAERS
22AsthmaFAERS: 34US FAERS
23Device defectiveFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Product taste abnormalFAERS: 33US FAERS
25Wrong technique in device usage processFAERS: 32US FAERS
26AstheniaFAERS: 28US FAERS
27AnxietyFAERS: 27US FAERS
28Weight decreasedFAERS: 27US FAERS
29HeadacheFAERS: 24US FAERS
30Incorrect dose administeredFAERS: 24US FAERS
31NasopharyngitisFAERS: 23US FAERS
32CataractFAERS: 21US FAERS
33BronchitisFAERS: 20US FAERS
34WheezingFAERS: 20US FAERS
35Intentional product use issueFAERS: 19US FAERS
36Frustration tolerance decreasedFAERS: 17US FAERS
37NervousnessFAERS: 17US FAERS
38StressFAERS: 17US FAERS
39Cerebrovascular accidentFAERS: 16US FAERS
40Oropharyngeal painFAERS: 15US FAERS
41Atrial FibrillationFAERS: 13US FAERS
42DementiaFAERS: 13US FAERS
43PainFAERS: 13US FAERS
44Chest discomfortFAERS: 12US FAERS
45NauseaFAERS: 12US FAERS
46AphoniaFAERS: 11US FAERS
47Diabetes MellitusFAERS: 11US FAERS
48LaryngitisFAERS: 11US FAERS
49PalpitationsFAERS: 11US FAERS
50Throat irritationFAERS: 11US FAERS
51Chest PainFAERS: 10US FAERS
52Medication ErrorFAERS: 10US FAERS
53Productive CoughFAERS: 10US FAERS
54Abdominal discomfortFAERS: 9US FAERS
55Adverse eventFAERS: 9US FAERS
56AmnesiaFAERS: 9US FAERS
57Extra dose administeredFAERS: 9US FAERS
58TremorFAERS: 9US FAERS
59Urinary RetentionFAERS: 9US FAERS
60VomitingFAERS: 9US FAERS
61BlindnessFAERS: 8US FAERS
62Drug dose omission by deviceFAERS: 8US FAERS
63HypersensitivityFAERS: 7US FAERS
64Myocardial InfarctionFAERS: 7US FAERS
65Respiratory tract congestionFAERS: 7US FAERS
66SepsisFAERS: 7US FAERS
67Activities of daily living impairedFAERS: 6US FAERS
68AgitationFAERS: 6US FAERS
69AngerFAERS: 6US FAERS
70Circumstance or information capable of leading to device use errorFAERS: 6US FAERS
71DehydrationFAERS: 6US FAERS
72Depressed moodFAERS: 6US FAERS
73Device use issueFAERS: 6US FAERS
74DysuriaFAERS: 6US FAERS
75General physical health deteriorationFAERS: 6US FAERS
76InfluenzaFAERS: 6US FAERS
77Mental impairmentFAERS: 6US FAERS
78OverdoseFAERS: 6US FAERS
79Product label issueFAERS: 6US FAERS
80PruritusFAERS: 6US FAERS
81SinusitisFAERS: 6US FAERS
82Therapy cessationFAERS: 6US FAERS
83ArthralgiaFAERS: 5US FAERS
84DeafnessFAERS: 5US FAERS
85Device difficult to useFAERS: 5US FAERS
86DisabilityFAERS: 5US FAERS
87Loss of personal independence in daily activitiesFAERS: 5US FAERS
88Macular degenerationFAERS: 5US FAERS
89Pulmonary HypertensionFAERS: 5US FAERS
90SomnolenceFAERS: 5US FAERS
91StomatitisFAERS: 5US FAERS
92SyncopeFAERS: 5US FAERS
93UrticariaFAERS: 5US FAERS
94ArthritisFAERS: 4US FAERS
95Back disorderFAERS: 4US FAERS
96ChokingFAERS: 4US FAERS
97EpistaxisFAERS: 4US FAERS
98HerniaFAERS: 4US FAERS
99Oral painFAERS: 4US FAERS
100PneumothoraxFAERS: 4US FAERS
101Product physical issueFAERS: 4US FAERS
102Pulmonary congestionFAERS: 4US FAERS
103Respiratory FailureFAERS: 4US FAERS
104Respiratory distressFAERS: 4US FAERS
105Secretion dischargeFAERS: 4US FAERS
106Throat cancerFAERS: 4US FAERS
107Accidental overdoseFAERS: 3US FAERS
108AgeusiaFAERS: 3US FAERS
109Back PainFAERS: 3US FAERS
110BronchospasmFAERS: 3US FAERS
111Clostridium difficile colitisFAERS: 3US FAERS
112Clostridium difficile infectionFAERS: 3US FAERS
113Drug DependenceFAERS: 3US FAERS
114Eye painFAERS: 3US FAERS
115Feeling jitteryFAERS: 3US FAERS
116Gastrointestinal infectionFAERS: 3US FAERS
117Gastrointestinal perforationFAERS: 3US FAERS
118GlaucomaFAERS: 3US FAERS
119Joint swellingFAERS: 3US FAERS
120Lip swellingFAERS: 3US FAERS
121Lower respiratory tract infectionFAERS: 3US FAERS
122Multiple SclerosisFAERS: 3US FAERS
123Neck PainFAERS: 3US FAERS
124OsteoporosisFAERS: 3US FAERS
125OverweightFAERS: 3US FAERS
126Pulmonary function test decreasedFAERS: 3US FAERS
127Pulmonary painFAERS: 3US FAERS
128Rheumatoid ArthritisFAERS: 3US FAERS
129Sleep disorder due to general medical condition, insomnia typeFAERS: 3US FAERS
130SneezingFAERS: 3US FAERS
131SwellingFAERS: 3US FAERS
132TachycardiaFAERS: 3US FAERS
133Unevaluable eventFAERS: 3US FAERS
134Urinary tract infectionFAERS: 3US FAERS
135VertigoFAERS: 3US FAERS
136Viral upper respiratory tract infectionFAERS: 3US FAERS
137AlopeciaFAERS: 2US FAERS
138Anal abscessFAERS: 2US FAERS
139AngioedemaFAERS: 2US FAERS
140ArthropathyFAERS: 2US FAERS
141Atypical pneumoniaFAERS: 2US FAERS
142Basal cell carcinomaFAERS: 2US FAERS
143Blood cholesterol increasedFAERS: 2US FAERS
144Carbon dioxide abnormalFAERS: 2US FAERS
145Chemical eye injuryFAERS: 2US FAERS
146Choking sensationFAERS: 2US FAERS
147CholelithiasisFAERS: 2US FAERS
148ColitisFAERS: 2US FAERS
149ConstipationFAERS: 2US FAERS
150DiscomfortFAERS: 2US FAERS
151DyspepsiaFAERS: 2US FAERS
152Ear discomfortFAERS: 2US FAERS
153EructationFAERS: 2US FAERS
154Expired product administeredFAERS: 2US FAERS
155Gastrointestinal obstructionFAERS: 2US FAERS
156General physical condition abnormalFAERS: 2US FAERS
157Head discomfortFAERS: 2US FAERS
158HyperkeratosisFAERS: 2US FAERS
159HyperventilationFAERS: 2US FAERS
160HypotensionFAERS: 2US FAERS
161InfectionFAERS: 2US FAERS
162Instillation site foreign body sensationFAERS: 2US FAERS
163Insurance issueFAERS: 2US FAERS
164Intracranial AneurysmFAERS: 2US FAERS
165Limb discomfortFAERS: 2US FAERS
166MYELODYSPLASTIC SYNDROMEFAERS: 2US FAERS
167MultimorbidityFAERS: 2US FAERS
168Musculoskeletal PainFAERS: 2US FAERS
169Musculoskeletal discomfortFAERS: 2US FAERS
170MyalgiaFAERS: 2US FAERS
171Non-cardiac chest painFAERS: 2US FAERS
172Obsessive-Compulsive DisorderFAERS: 2US FAERS
173Panic DisorderFAERS: 2US FAERS
174Peripheral swellingFAERS: 2US FAERS
175PharyngitisFAERS: 2US FAERS
176PleurisyFAERS: 2US FAERS
177Poor peripheral circulationFAERS: 2US FAERS
178Product packaging quantity issueFAERS: 2US FAERS
179Product physical consistency issueFAERS: 2US FAERS
180Product substitution issueFAERS: 2US FAERS
181Product use complaintFAERS: 2US FAERS
182Pulmonary FibrosisFAERS: 2US FAERS
183Respiratory tract irritationFAERS: 2US FAERS
184RetchingFAERS: 2US FAERS
185Rotator cuff syndromeFAERS: 2US FAERS
186Slow speechFAERS: 2US FAERS
187Spinal column stenosisFAERS: 2US FAERS
188TensionFAERS: 2US FAERS
189Tongue discomfortFAERS: 2US FAERS
190Upper-airway cough syndromeFAERS: 2US FAERS
191Vocal Cord ParalysisFAERS: 2US FAERS
192Walking aid userFAERS: 2US FAERS
193kyphosisFAERS: 2US FAERS
194Abdominal PainFAERS: 1US FAERS
195Acute kidney injuryFAERS: 1US FAERS
196Anal FissureFAERS: 1US FAERS
197Ankle FractureFAERS: 1US FAERS
198Aortic Valve StenosisFAERS: 1US FAERS
199AsphyxiaFAERS: 1US FAERS
200BedriddenFAERS: 1US FAERS
201Bladder NeoplasmFAERS: 1US FAERS
202Blood urine presentFAERS: 1US FAERS
203Body fat disorderFAERS: 1US FAERS
204BronchiectasisFAERS: 1US FAERS
205Burning sensationFAERS: 1US FAERS
206Cancer PainFAERS: 1US FAERS
207Capillary FragilityFAERS: 1US FAERS
208Cardiac ArrestFAERS: 1US FAERS
209ChillsFAERS: 1US FAERS
210Complication associated with deviceFAERS: 1US FAERS
211Contraindicated product administeredFAERS: 1US FAERS
212Device occlusionFAERS: 1US FAERS
213Device related infectionFAERS: 1US FAERS
214Disease ProgressionFAERS: 1US FAERS
215DisorientationFAERS: 1US FAERS
216DiverticulitisFAERS: 1US FAERS
217Drug administration errorFAERS: 1US FAERS
218Drug dispensing errorFAERS: 1US FAERS
219Drug ineffective for unapproved indicationFAERS: 1US FAERS
220Drug screen false positiveFAERS: 1US FAERS
221DysarthriaFAERS: 1US FAERS
222Eye allergyFAERS: 1US FAERS
223Eye irritationFAERS: 1US FAERS
224Feeling ColdFAERS: 1US FAERS
225Feelings of worthlessnessFAERS: 1US FAERS
226FibromyalgiaFAERS: 1US FAERS
227FlatulenceFAERS: 1US FAERS
228FlushingFAERS: 1US FAERS
229Gait inabilityFAERS: 1US FAERS
230Gastrointestinal carcinomaFAERS: 1US FAERS
231GlossitisFAERS: 1US FAERS
232Inappropriate schedule of drug administrationFAERS: 1US FAERS
233IncoherentFAERS: 1US FAERS
234Incorrect dose administered by deviceFAERS: 1US FAERS
235Incorrect dose administered by productFAERS: 1US FAERS
236Increased upper airway secretionFAERS: 1US FAERS
237Inspiratory capacity decreasedFAERS: 1US FAERS
238Intentional device use issueFAERS: 1US FAERS
239Intestinal ObstructionFAERS: 1US FAERS
240Intraocular pressure test abnormalFAERS: 1US FAERS
241Intraocular pressure testFAERS: 1US FAERS
242LethargyFAERS: 1US FAERS
243Limb injuryFAERS: 1US FAERS
244LymphomaFAERS: 1US FAERS
245Malignant neoplasm progressionFAERS: 1US FAERS
246Metabolic acidosisFAERS: 1US FAERS
247Metastases to reproductive organFAERS: 1US FAERS
248Micturition frequency decreasedFAERS: 1US FAERS
249Middle insomniaFAERS: 1US FAERS
250Nasal discomfortFAERS: 1US FAERS
251Ocular discomfortFAERS: 1US FAERS
252Oral candidiasisFAERS: 1US FAERS
253Ovarian cancer stage IIIFAERS: 1US FAERS
254Ovarian enlargementFAERS: 1US FAERS
255Oxygen saturation abnormalFAERS: 1US FAERS
256Oxygen saturation increasedFAERS: 1US FAERS
257Packaging design issueFAERS: 1US FAERS
258Post procedural infectionFAERS: 1US FAERS
259Product outer packaging issueFAERS: 1US FAERS
260Product packaging issueFAERS: 1US FAERS
261Product residue presentFAERS: 1US FAERS
262Product storage errorFAERS: 1US FAERS
263Pulmonary thrombosisFAERS: 1US FAERS
264RhinitisFAERS: 1US FAERS
265RosaceaFAERS: 1US FAERS
266ShockFAERS: 1US FAERS
267Sinus headacheFAERS: 1US FAERS
268Skin irritationFAERS: 1US FAERS
269SluggishnessFAERS: 1US FAERS
270StaringFAERS: 1US FAERS
271Status AsthmaticusFAERS: 1US FAERS
272Stevens-Johnson SyndromeFAERS: 1US FAERS
273Terminal stateFAERS: 1US FAERS
274Therapeutic response changedFAERS: 1US FAERS
275ThrombosisFAERS: 1US FAERS
276TinnitusFAERS: 1US FAERS
277Tongue blisteringFAERS: 1US FAERS
278Tooth ExtractionFAERS: 1US FAERS
279Urinary hesitationFAERS: 1US FAERS
280Urine flow decreasedFAERS: 1US FAERS
281Vitreous floatersFAERS: 1US FAERS
282Wrong doseFAERS: 1US FAERS
283Wrong drug administeredFAERS: 1US FAERS
284YawningFAERS: 1US FAERS
285skin abrasionFAERS: 1US FAERS
286DiplopiaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.